Final Word - BioPharm International

ADVERTISEMENT

Final Word
  • Disposable Decisions



    To achieve the right balance between disposable and reuseable options, companies must consider important technical and economic factors.

    Connecting the Manufacturing Process to Patient Wellness



    Manufacturers of biopharmaceuticals can improve productivity by taking patient wellness into account.

    10 Key Ways to Align Your Strategy with Execution



    Best practices a pharmaceutical company can follow to execute their strategy sucessfully.

    Validation Failure is Not an Option. Should it be?



    The industry needs to open up to validation failures.

    Managing the Global Supply Chain



    Recent problems with food and pharmaceutical ingredients sourced from China highlight a major disadvantage of our complex international supply chains for food and drug ingredients. A global supply chain offers more opportunities for accidental contamination as well as intentional adulteration and counterfeiting. Sticking to minimal requirements may not be enough.

    Pharmaceutical Quality Success: It's All About Management


    Engaging executive leadership in the quality process is the key to compliance success.

    Can the FDA Live up to its Promise of a Risk-Based Approach to Compliance?


    The expanding globalization of the industry poses a challenge for international enforcement.

    The Role of Analytical Science in the Debate over Biosimilars



    Both innovator and generics companies are using analytics to support comparability arguments.

    Evaluating China's Intellectual Property Situation



    The Chinese government is making consistent efforts to strengthen IP protection.

ADVERTISEMENT

ADVERTISEMENT

Advertiser Gallery
Click here